Effect of dupilumab on genital condylomata: a case report

Sex Transm Infect. 2022 Feb;98(1):73. doi: 10.1136/sextrans-2021-055301. Epub 2021 Nov 5.

Authors

Angelo Massimiliano D'Erme¹, Cristian Fidanzi², Giovanni Bagnoni³, Simone Pardossi⁴, Flavia Manzo Margiotta⁴, Agata Janowska², Valentina Dini², Marco Romanelli²

Affiliations

¹ Unit of Dermatology and Melanoma & Skin Cancer Unit AVNO, Livorno Hospital, Livorno, Italy a.m.derme@gmail.com.
² Unit of Dermatology, University of Pisa, Pisa, Toscana, Italy.
³ Unit of Dermatology and Melanoma & Skin Cancer Unit AVNO, Livorno Hospital, Livorno, Italy.
⁴ Sant'Anna Advanced School of University Studies and Improvement, Pisa, Toscana, Italy.

PMID: 34740977
DOI: 10.1136/sextrans-2021-055301

No abstract available

Keywords: Papillomaviridae; condylomata acuminata; dermatology; genital diseases; inflammation; male.

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Condylomata Acuminata / diagnosis
Condylomata Acuminata / drug therapy*
Genitalia / drug effects*
Genitalia / pathology
Genitalia / virology
Humans
Male
Middle Aged
Papillomaviridae / drug effects*
Papillomaviridae / pathogenicity

Substances

Antibodies, Monoclonal, Humanized
dupilumab